Same Indication

Memantine vs Upadacitinib

Memantine vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Memantine and Upadacitinib.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Memantine — 60-80 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N; Upadacitinib — C17H19F3N6O.

Molecular Weight: Memantine — 179.3080 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Memantine — Small molecule; Upadacitinib — Small molecule.